Envisia (Envisia Therapeutics, Inc.) was a clinical-stage biopharmaceutical company based in Research Triangle Park, North Carolina, spun out of Liquidia Technologies to apply PRINT (Particle Replication In Non-wetting Templates) particle-engineering to sustained-release ophthalmic therapeutics. - View it on GitHub